Top Markets
#1 Bitway Bitway +50.82%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +41.43%
#3 Pons Pons +36.47%
#4 Starpower Starpower +29.47%
#5 Mubarak Mubarak +28.46%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +27.98%
#7 Ocean Protocol Ocean Protocol +22.74%
#8 StonkBroker StonkBroker +21.51%
#9 SkyAI SkyAI +20.24%
#10 PondCoin PondCoin +18.22%
Coin of the day
Bitway Bitway
설정
언어
한국어
통화
USD
테마
Modalis Therapeutics Corporation Modalis Therapeutics Corporation

Modalis Therapeutics Corporation

4883
주식 순위 #29677
Modalis Therapeutics Corporation focuses on discovering and developing... Modalis Therapeutics Corporation focuses on discovering and developing treatments for severe genetic conditions. The company utilizes its proprietary CRISPR-GNDM technology to create therapies by controlling gene expression through the epigenetic modulation of specific genetic loci. Modalis also has a collaborative research agreement with JCR Pharmaceuticals Co., Ltd., aimed at assessing gene therapy drug delivery methods for the central nervous system (CNS), particularly for CNS-related disorders. Founded in 2016, the company was initially known as EdiGENE Corporation before changing its name to Modalis Therapeutics Corporation in August 2019. Its operations are based in Tokyo, Japan.
주가
$0.20877985
시가총액
$20.11M
변동 (1일)
-3.03%
변동 (1년)
-66.13%
국가
JP
거래 Modalis Therapeutics Corporation (4883)

카테고리

Healthcare
Modalis Therapeutics Corporation (4883)의 배당 이력
Modalis Therapeutics Corporation (주식 심볼: 4883)은 총 0회의 배당금을 지급했습니다.
모든 배당금의 합계 (주식 분할 반영): 0.00
배당 수익률 (TTM): 0
Modalis Therapeutics Corporation (4883)의 2026부터 2026까지 배당 지급 내역
연간 배당 지급
연도 배당금 (주식 분할 조정됨) 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
모든 배당 지급 목록
연도 배당금 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 배당 지급
회사 배당 지급 횟수 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH